BGB-A3055

· BeiGene

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BGB-A3055, covering 2026-03-13 to 2026-03-13. Get the full timeline:

Most recent: Clinical Trial Update: BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors [Phase 1]